The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial
Abstract
This study was designed to assess the efficacy and safety of pregabalin-a novel alpha(2)-delta ligand with analgesic, anxiolytic, and anticonvulsant activity-for treating neuropathic pain in patients with post-herpetic neuralgia (PHN). Two hundred and thirty-eight patients were randomised into this multicentre, doubleblind, placebo-controlled trial to receive 150 (n=81), 300 mg/day (n=76) pregabalin, or placebo (n=81) for 8 weeks. Among the exclusion criteria was failure to respond to previous treatment for PHN with gabapentin at doses > or =1200 mg/day. Endpoint mean pain scores were significantly reduced in patients receiving 150 or 300 mg/day pregabalin compared with placebo. Efficacy was observed as early as week 1 and was maintained throughout the study. Significantly more patients in both pregabalin groups (150 mg, 26%; 300 mg, 28%) were responders (> or =50% decrease in mean pain score from baseline to endpoint) than in the placebo group (10%). Additionally, by week 1 and for the study's duration, 150 and 300 mg/day pregabalin significantly reduced weekly mean sleep interference scores. More pregabalin-treated patients than placebo-treated patients reported that they were 'much improved' or 'very much improved'. Health-related quality-of-life (HRQoL) measurements using the SF-36 Health Survey demonstrated improvement in the mental health domain for both pregabalin dosages, and bodily pain and vitality domains were improved in the 300 mg/day group. The most frequent adverse events were dizziness, somnolence, peripheral oedema, headache, and dry mouth. Pregabalin efficaciously treated the neuropathic pain of PHN. Additionally, pregabalin was associated with decreased sleep interference and significant improvements in HRQoL measures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
A self-rating depression scale
ZUNG, W. W. K. (1965) · Archives of General Psychiatry · doi:10.1001/archpsyc.1965.01720310065008 · Cited by 9,813
Farrar, J. T., Young, J. P., LaMoreaux, L., Werth, J. L., & Poole, M. R. (2001) · Pain · doi:10.1016/s0304-3959(01)00349-9 · Cited by 5,808
The short-form McGill pain questionnaire
Melzack, R. (1987) · Pain · doi:10.1016/0304-3959(87)91074-8 · Cited by 4,368
Backonja, M. (1998) · JAMA · doi:10.1001/jama.280.21.1831 · Cited by 1,533
Persistent Pain and Well-being: A World Health Organization Study in Primary Care
Gureje, O., Von Korff, M., Simon, G. E., & Gater, R. (1998) · JAMA · doi:10.1001/jama.280.2.147 · Cited by 1,496
Rowbotham, M. (1998) · JAMA · doi:10.1001/jama.280.21.1837 · Cited by 1,433
The Novel Anticonvulsant Drug, Gabapentin (Neurontin), Binds to the α2δ Subunit of a Calcium Channel
Gee, N. S., Brown, J. P., Dissanayake, V. U. K., Offord, J., Thurlow, R., & Woodruff, G. N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5768 · Cited by 1,181
The Management of Persistent Pain in Older Persons: AGS Panel on Persistent Pain in Older Persons
(2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.50.6s.1.x · Cited by 1,139
Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial
Dworkin, R. H., Corbin, A. E., Young, J. P., Sharma, U., LaMoreaux, L., Bockbrader, H., Garofalo, E. A., & Poole, R. M. (2003) · Neurology · doi:10.1212/01.wnl.0000055433.55136.55 · Cited by 768
Efficacy of oxycodone in neuronathic pain: A randomized trial in postherpetic neuralgia
N. Watson, C. P., & Babul, N. (1998) · Neurology · doi:10.1212/wnl.50.6.1837 · Cited by 646
Postherpetic Neuralgia — Pathogenesis, Treatment, and Prevention
Kost, R. G., & Straus, S. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350107 · Cited by 641
Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study
Rice, A. S. C., & Maton, S. (2001) · Pain · doi:10.1016/s0304-3959(01)00407-9 · Cited by 596
Amitriptyline versus placebo in postherpetic neuralgia
Watson, C. P., Evans, R. J., Reed, K., Merskey, H., Goldsmith, L., & Warsh, J. (1982) · Neurology · doi:10.1212/wnl.32.6.671 · Cited by 559
Inhibition of neuronal Ca2+ influx by gabapentin and pregabalin in the human neocortex
Fink, K., Dooley, D. J., Meder, W. P., Suman-Chauhan, N., Duffy, S., Clusmann, H., & Göthert, M. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00172-1 · Cited by 496
Amitriptyline, but not lorazepam, relieves postherpetic neuralgia
Max, M. B., Schafer, S. C., Culnane, M., Smoller, B., Dubner, R., & Gracely, R. H. (1988) · Neurology · doi:10.1212/wnl.38.9.1427 · Cited by 402
Pain and its persistence in herpes zoster
Dworkin, R. H., & Portenoy, R. K. (1996) · Pain · doi:10.1016/0304-3959(96)03122-3 · Cited by 396
Nortriptyline versus amitriptyline in postherpetic neuralgia: A randomized trial
Watson, C. P. N., Vernich, L., Chipman, M., & Reed, K. (1998) · Neurology · doi:10.1212/wnl.51.4.1166 · Cited by 319
Helgason, S. (2000) · BMJ · doi:10.1136/bmj.321.7264.794 · Cited by 268
Inhibition of K+-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin
Dooley, D. J., Mieske, C. A., & Borosky, S. A. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00769-2 · Cited by 226
Dooley, D. J., Donovan, C. M., & Pugsley, T. A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39009-3 · Cited by 217
Maneuf, Y. P., Hughes, J., & McKnight, A. T. (2001) · Pain · doi:10.1016/s0304-3959(01)00316-5 · Cited by 184
Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV)
Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Loiseau, P., & Perucca, E. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(98)00108-9 · Cited by 179
The Treatment of Neuropathic Pain: Antidepressants and Opioids
Watson, P. C. N. (2000) · Clinical Journal of Pain · doi:10.1097/00002508-200006001-00009 · Cited by 147
Gabapentin as a novel treatment for postherpetic neuralgia
Segal, A. Z., & Rordorf, G. A. (1996) · Neurology · doi:10.1212/wnl.46.4.1175 · Cited by 111
Systemic gabapentin and S(+)-3-isobutyl-γ-aminobutyric acid block secondary hyperalgesia
Jones, D. L., & Sorkin, L. S. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00890-7 · Cited by 103
A prognostic score for postherpetic neuralgia in ambulatory patients
Meister, W., Neiß, A., Gross, G., Doerr, H. W., Höbel, W., Malin, J.-P., von Essen, J., Reimann, B.-Y., Witke, C., & Wutzler, P. (1998) · Infection · doi:10.1007/bf02770836 · Cited by 70
Postherpetic neuralgia in immunocompetent elderly people
Schmader, K. E. (1998) · Vaccine · doi:10.1016/s0264-410x(98)00137-6 · Cited by 62
Pregabalin Enhances Nonrapid Eye Movement Sleep
Kubota, T., Fang, J., Meltzer, L. T., & Krueger, J. M. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29233-8 · Cited by 53
Patients' experiences of herpes zoster and postherpetic neuralgia
Engberg, I. B., Grondahl, G., & Thibom, K. (1995) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.1995.tb02723.x · Cited by 25
Managing post-herpetic neuralgia with opioids and local anesthetics
Rowbotham, M. C. (1994) · Annals of Neurology · doi:10.1002/ana.410350714 · Cited by 24
Cited by
Pharmacologic management of neuropathic pain: Evidence-based recommendations
Dworkin, R. H., O’Connor, A. B., Backonja, M., Farrar, J. T., Finnerup, N. B., Jensen, T. S., Kalso, E. A., Loeser, J. D., Miaskowski, C., Nurmikko, T. J., et al. (2007) · Pain · doi:10.1016/j.pain.2007.08.033 · Cited by 2,126
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873
Algorithm for neuropathic pain treatment: An evidence based proposal
Finnerup, N. B., Otto, M., McQuay, H. J., Jensen, T. S., & Sindrup, S. H. (2005) · Pain · doi:10.1016/j.pain.2005.08.013 · Cited by 1,330
EFNS guidelines on pharmacological treatment of neuropathic pain
Attal, N., Cruccu, G., Haanpää, M., Hansson, P., Jensen, T. S., Nurmikko, T., Sampaio, C., Sindrup, S., & Wiffen, P. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01511.x · Cited by 880
Yawn, B. P., Saddier, P., Wollan, P. C., Sauver, J. L. S., Kurland, M. J., & Sy, L. S. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.11.1341 · Cited by 867
Metadata
- Authors
- Sabatowski, R., Gálvez, R., Cherry, D. A., Jacquot, F., Vincent, E., Maisonobe, P., & Versavel, M.
- Venue
- Pain
- Published
- 2004-05
- Volume
- 109
- Issue
- 1
- Pages
- 26-35
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2070246197
- Cited by
- 527
- References
- 33
- FWCI
- 25.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.